Thu, October 13, 2022
Wed, October 12, 2022
Tue, October 11, 2022
Mon, October 10, 2022
Sun, October 9, 2022
Fri, October 7, 2022

Matthew Harrison Upgraded (AMGN) to Buy and Increased Target to $279 on, Oct 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-increased-target-to-279-on-oct-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Upgraded "Amgen Inc." (AMGN) to Buy and Increased Target from $257 to $279 on, Oct 11th, 2022.

Matthew has made no other calls on AMGN in the last 4 months.



There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $236 on, Friday, August 5th, 2022


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Steve Chesney of "Atlantic Equities" Maintained at Sell with Decreased Target to $182 on, Tuesday, August 9th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $265 on, Friday, August 5th, 2022

Publication Contributing Sources